H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant

The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma

(2016) M Fernanda Amary et al.   HISTOPATHOLOGY

Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma

(2015) Arjen H.G. Cleven et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAFmutations

(2014) Michaela Angelika Ihle et al.   BMC CANCER

Pulmonary metastasis of giant cell tumor of bones

(2014) Aikeremujiang Muheremu et al.   World Journal of Surgical Oncology

Histone H3.3 Mutations: A Variant Path to Cancer

(2013) Benjamin T.K. Yuen et al.   CANCER CELL

Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas

(2013) Christine G. Joseph et al.   GENES CHROMOSOMES & CANCER

Denosumab treatment of giant cell tumour of bone

(2013) Maurice Balke   LANCET ONCOLOGY

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

(2013) Sam Behjati et al.   NATURE GENETICS

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

(2012) D. G. Branstetter et al.   CLINICAL CANCER RESEARCH

Metastasis of Osteosarcoma After 16 Years

(2010) Jana Ellegast et al.   JOURNAL OF CLINICAL ONCOLOGY

Denosumab: a breakthrough in treatment of giant-cell tumour of bone?

(2010) Maurice Balke et al.   LANCET ONCOLOGY

Functions of RANKL/RANK/OPG in bone modeling and remodeling

(2008) Brendan F. Boyce et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Giant cell tumor of bone: treatment and outcome of 214 cases

(2008) Maurice Balke et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY